https://www.selleckchem.com/pr....oducts/forskolin.htm
BACKGROUND The Papillomavirus Rapid Interface for Modelling and Economics (PRIME) has been used around the world to assess the health impact and cost-effectiveness of human papillomavirus (HPV) vaccination in girls. We updated PRIME with new data and methods for demography, disability weights, and cervical cancer burden, and generated revised estimates of the health impact of HPV vaccination at the global, regional, and national levels for 177 countries. METHODS PRIME was updated with population demography of the UN World Population P
Like
Comment
Share
